New study in Nature Communications👉Exemestane plus everolimus and palbociclib in #MetastaticBreastCancer : Clinical response & genomic/transcriptomic determinants of resistance in a phase I/II trial Ann Partridge MD, MPH Nancy Lin, MD Sara Tolaney Nikhil Wagle, MD (he/him) Nabihah Tayob
👉pubmed.ncbi.nlm.nih.gov/38503755/

Dr. Wagle (Nikhil Wagle, MD (he/him)) offered insights on how to maximize the impact of translational research and wondered what we need to make translational data sets more impactful.
Join the Genomic Approaches Toward Precision Cancer Medicine Symposium here⬇️
dfci-ccg.github.io/symposium/inde…

.Kimmie Ng, MD, MPH highlights Count Me In, a new digital platform where young-onset cancer patients can gather and aggregate their experiences with the goal of accelerating research

#GI24

Did someone say there was a new study to understand heart disease risk in South Asians?
ourhealthstudy.org 💜

Thrilled to officially launch OurHealth!
Help us identify the reasons why South Asian Americans are at increased risk for heart disease, stroke, diabetes, & others.
A new virtual & community-based nationwide initiative to build the infrastructure. ourhealthstudy.org

Congratulations Dan! Great to hear

Congrats to Nayan Lamba, MD on a fantastic oral presentation on her study of genomic alterations associated w brain met response to radiotherapy. Findings could help identify patients who benefit most from radiation. Thx to Conquer Cancer, the ASCO Foundation YIA for supporting Nayan this year #asco23

Thrilled to be back at #ASCO23 in person for the first time in 4 years. Congrats & thank you Lynn M. Schuchter, MD, FASCO, Kimmie Ng, MD, MPH and the whole @ASCO team on a fantastic meeting. Great to see so many friends and colleagues in person for the first time in ages. Need to do this again soon!

“I hope to be one of those people with cancer who live a full and active life free from cancer’s harmful effects. What has given me this hope? Science. Research. All that we celebrate at each ASCO Annual Meeting.” -Dr. Kimryn Rathmell #ASCO23 #NationalCancerSurvivorsMonth

The question is what have I learned from this chronicle that could be helpful to all of you, and more specifically, how does my experience contribute to our collective understanding of partnerships between patients and clinicians in oncology? I have some thoughts.... 1/4 #ASCO23

Getting ready for #ASCO23 opening session and making time to connect with friends and colleagues like ASCO CEO @cliffordhudis. Hope you’ll join me this morning as I discuss the importance of partnering with patients.

In May 2019, Dr. Richard Schilsky & I co-chaired the #AAADV19 Workshop Plenary Session 'Decentralized #ClinicalTrials : The Future is Now.' An incredible group of panelists from academia, industry, govt, & patient #advocacy 👇discussed the rationale, challenges, & opportunities of DCTs.

Assistant Professor svastiharicharan is unpacking the barriers preventing cancer disparities research from moving forward. Read our interview with her: bit.ly/43VuKrl #cancerresearch #nmhm Health Disparities

I’m really thankful for my time with wonderful colleagues at BIDMC, and incredibly excited for this opportunity to join an amazing team at UCSF🫀👍🏽☀️ See you soon SF and UCSF Cardiology!

Welcome Dr. Shweta Motiwala! Dr. Motiwala joins UCSF Health in September from Beth Israel Lahey Health. We are excited to have her join the faculty and lead the effort to develop a #HeartFailure Chronic Disease Management program within UCSF Heart & Vascular Care. #WomenInCardiology

📣New Pub | Adjuvant paclitaxel and trastuzumab for node-negative, HER2+ #breastcancer : Final 10-yr analysis of the open-label, single-arm, phase 2 APT trial is now available from The Lancet Oncology free until 4/18! Congrats to Sara Tolaney Paolo Tarantino et al
authors.elsevier.com/a/1gfxW5EIIgLp…

Dr. Cristina Guarducci presents research on Clonal evolution and mechanisms of acquired resistance to CDK4/6 inhibitors in ER-wild type and ER-mutant breast cancer at @SABCS22 Rinath Jeselsohn Simona Cristea Agostina Nardone Myles Brown

Beautiful presentation by Erica Mayer of the PACE trial looking to address continuation of palbociclib beyond progression on prior CDK 4/6i

No improvement in PFS seen: 4.6 mo vs 4.8 mo

Interesting signal for fulvestrant + palbo + avelumab (PFS 8.1 mo)

OncoAlert #bcsm #SABCS22

Dr. Erica Mayer (Erica Mayer) presents her research on Palbociclib After CDK4/6i and Endocrine Therapy (PACE): A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab for Endocrine Pre-treated ER+/HER2- Metastatic #BreastCancer #BMC #SABCS22

New research led by Ana Garrido-Castro on the Dynamics of HER2-low expression in triple-negative breast cancer presented in the #HER2 Poster Session at #SABCS22
Nikhil Wagle, MD (he/him) Nancy Lin, MD Eric Winer, MD Tari King MD Sara Tolaney Dr. E Mittendorf Paolo Tarantino Jorge Gómez Tejeda Zañudo #TNBC #BCSM